Assess the Efficacy and Tolerability of Antistax Film-coated Tablets in Patients With Chronic Venous Insufficiency
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of AbGn-168 in Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1
Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery
- Status
- COMPLETED
- Phase
- N/A
Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery
- Status
- COMPLETED
- Phase
- N/A
BI 1744 CL With Respimat Once Daily Versus Twice Daily in COPD
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Tolerability of Dabigatran Etexilate in Adolescents
- Status
- COMPLETED
- Phase
- PHASE2
Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE4
6 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or Trastuzumab
- Status
- COMPLETED
- Phase
- PHASE2
Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Japanese Patients With COPD
- Status
- COMPLETED
- Phase
- PHASE2
Randomized, Double-blind (db), Placebo-controlled 18 Week Study of Linagliptin (BI 1356) in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug
- Status
- COMPLETED
- Phase
- PHASE3
Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected Patients
- Status
- COMPLETED
- Phase
- PHASE3
Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary Intervention
- Status
- COMPLETED
- Phase
- PHASE2
4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma
- Status
- COMPLETED
- Phase
- PHASE2
Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial
- Status
- COMPLETED
- Phase
- PHASE3
Sensitivity of New Exercise Tests in Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- NA
Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC
- Status
- COMPLETED
- Phase
- PHASE3
Surveillance Cohort Long-term Toxicity Antiretrovirals in HIV-infected Patients Enrolled in TPV Cohort
- Status
- WITHDRAWN
- Phase
- N/A
LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3